Natalizumab in Multiple Sclerosis: Long-Term Management-Reference-Cited by-同舟云学术

Natalizumab in Multiple Sclerosis: Long-Term Management

Published:2017-04-29 Issue:5 Volume:18 Page:940
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Clerico Marinella,Artusi Carlo,Liberto Alessandra,Rolla Simona^ORCID,Bardina Valentina,Barbero Pierangelo,Mercanti Stefania,Durelli Luca

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/5/940/pdf

Reference81 articles.

1. Multiple sclerosis: Prospects and promise

2. MS Prevalence: National MS Society Study for New Prevalence Estimatehttp://www.nationalmssociety.org/About-the-Society/MSPrevalence

3. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis;Tullman;Am. J. Manag. Care,2013

4. Pathogenesis of multiple sclerosis

5. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: Cell distribution and antigenic relation to components on resting cells and T cell lines;Hemler;J. Immunol.,1984

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KG-LIME: predicting individualized risk of adverse drug events for multiple sclerosis disease-modifying therapy;Journal of the American Medical Informatics Association;2024-07-04

2. An update on managing patients with multiple sclerosis in primary care;JAAPA;2024-01-17

3. Anti-CD20-Triggered Crohn’s-Like Disease with Severe Perianal Involvement in a Patient with Multiple Sclerosis: Case Report, Review of the Literature, and Potential Therapeutic Approach;Sclerosis;2024-01-16

4. Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab;Neurodegenerative Disease Management;2024-01-02

5. The Plausible Role of Vascular Adhesion Molecules in Cardiovascular Diseases;Cardiovascular Innovations and Applications;2024